share_log

Aprea Therapeutics Q1 EPS $(0.67) Beats $(0.78) Estimate, Sales $380.57K

Aprea Therapeutics Q1 EPS $(0.67) Beats $(0.78) Estimate, Sales $380.57K

Aprea Therapeutics第一季度每股收益美元(0.67美元)超過預期(0.78美元),銷售額爲380.57萬美元
Benzinga ·  05/14 20:47

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.78) by 14.1 percent. This is a 50 percent increase over losses of $(1.34) per share from the same period last year. The company reported $380.57 thousand in sales this quarter.

Aprea Therapeutics(納斯達克股票代碼:APRE)公佈的季度虧損爲每股0.67美元,比分析師普遍預期的0.78美元(0.78美元)高出14.1%。這比去年同期每股虧損1.34美元(1.34)增加了50%。該公司報告本季度銷售額爲380,570美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論